Notice of Closed Meeting, 61767 [2021-24322]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 213 / Monday, November 8, 2021 / Notices
The meeting will be held on
October 20–21, 2021, from 10:00 a.m. to
5:00 p.m., EDT (times subject to
change). The docket is currently open to
receive written comments. Written
comments must be received on or before
October 21, 2021.
SUPPLEMENTARY INFORMATION: Notice is
hereby given of a change in the meeting
of the Advisory Committee on
Immunization Practices (ACIP); October
20, 2021, 10:00 a.m.–5:00 p.m., EDT,
and October 21, 2021, 10:00 a.m.–5:00
p.m., EDT (times subject to change), in
the original FRN.
The virtual meeting was published in
the Federal Register on Wednesday,
September 22, 2021, Volume 86,
Number 181, pages 52683–52684.
The virtual meeting is being amended
to change the date the docket was
opened to receive written public
comments, and updates to the Matters
To Be Considered and Written Public
Comment sections of the notice and
should read as follows:
DATES: The meeting will be held on
October 20–21, 2021, from 10:00 a.m. to
5:00 p.m., EDT (times subject to
change). The public may submit written
comments from October 7, 2021 through
October 21, 2021.
Matters To Be Considered: The agenda
will include discussions on herpes
zoster vaccines, influenza vaccines,
pneumococcal vaccine, and COVID–19
vaccines. Recommendation votes on
herpes zoster vaccine, pneumococcal
vaccine, and COVID–19 vaccines are
scheduled. No Vaccines for Children
(VFC) votes are scheduled. Agenda
items are subject to change as priorities
dictate. For more information on ACIP
please visit the ACIP website: https://
www.cdc.gov/vaccines/acip/.
Written Public Comment: The docket
will be opened to receive written
comments on October 7, 2021. Written
comments must be received on or before
October 21, 2021.
The virtual meeting is open to the
public.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee
Management Specialist, Centers for
Disease Control and Prevention,
National Center for Immunization and
Respiratory Diseases, 1600 Clifton Road
NE, MS–H24–8, Atlanta, GA 30329–
4027; Telephone: 404–639–8367; Email:
ACIP@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
lotter on DSK11XQN23PROD with NOTICES1
DATES:
VerDate Sep<11>2014
18:37 Nov 05, 2021
Jkt 256001
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
61767
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–24322 Filed 11–5–21; 8:45 am]
BILLING CODE 4163–18–P
[FR Doc. 2021–24320 Filed 11–5–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—RFA–CK–22–003,
Emerging Infections Sentinel Networks
(EISN) Research.
Date: January 11, 2022.
Time: 10:00 a.m.–5:00 p.m., EST.
Place: Teleconference, Centers for Disease
Control and Prevention, Room 1080, 8
Corporate Square Boulevard, Atlanta, Georgia
30329–4027.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Gregory
Anderson, M.S., M.P.H., Scientific Review
Officer, National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention, CDC,
1600 Clifton Road NE, Mailstop US8–1,
Atlanta, Georgia 30329–4027, Telephone:
(404) 718–8833, Email: GAnderson@cdc.gov.
The Director, Strategic Business Initiatives
Unit, Office of the Chief Operating Officer,
Centers for Disease Control and Prevention,
has been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10280]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
Comments on the collection(s) of
information must be received by the
OMB desk officer by December 8, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
DATES:
E:\FR\FM\08NON1.SGM
08NON1
]]>Agencies
[Federal Register Volume 86, Number 213 (Monday, November 8, 2021)]
[Notices]
[Page 61767]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-24322]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention
and Control Special Emphasis Panel (SEP)--RFA-CK-22-003, Emerging
Infections Sentinel Networks (EISN) Research.
Date: January 11, 2022.
Time: 10:00 a.m.-5:00 p.m., EST.
Place: Teleconference, Centers for Disease Control and
Prevention, Room 1080, 8 Corporate Square Boulevard, Atlanta,
Georgia 30329-4027.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention, CDC, 1600 Clifton Road NE,
Mailstop US8-1, Atlanta, Georgia 30329-4027, Telephone: (404) 718-
8833, Email: [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-24322 Filed 11-5-21; 8:45 am]
BILLING CODE 4163-18-P
